(Q37536067)

20 August 2017

1 reference

title

Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications (English)

1 reference

20 August 2017

cardiovascular disease

1 reference

Jianli Niu

1

1 reference

PubMed ID

19566488

20 August 2017

Pappachan E Kolattukudy

series ordinal

2

1 reference

PubMed ID

19566488

20 August 2017

language of work or name

English

0 references

publication date

2 July 2009

1 reference

20 August 2017

1 reference

20 August 2017

117

1 reference

20 August 2017

95-109

1 reference

20 August 2017

3

1 reference

Protecting the pump: controlling myocardial inflammatory responses

20 August 2017

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

The role of innate immune responses in the heart in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Targeting monocyte chemoattractant protein-1 signalling in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Chemokines, leukocytes, and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

IL-13-induced chemokine responses in the lung: role of CCR2 in the pathogenesis of IL-13-induced inflammation and remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Chemokine receptor CCR2 expression and monocyte chemoattractant protein-1-mediated chemotaxis in human monocytes. A regulatory role for plasma LDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

CCR2 deficiency decreases intimal hyperplasia after arterial injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Examination of genetic effects of polymorphisms in the MCP-1 and CCR2 genes on MI in the Icelandic population

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Val64Ile polymorphism in the C-C chemokine receptor 2 is associated with reduced coronary artery calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Interaction between chemokines and oxidative stress: possible pathogenic role in acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Association of sICAM-1 and MCP-1 with coronary artery calcification in families enriched for coronary heart disease or hypertension: the NHLBI Family Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Essential role of monocyte chemoattractant protein-1 in development of restenotic changes (neointimal hyperplasia and constrictive remodeling) after balloon angioplasty in hypercholesterolemic rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

JE mRNA accumulates rapidly in aortic injury and in platelet-derived growth factor-stimulated vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Induction of monocyte chemoattractant protein-1 in the small veins of the ischemic and reperfused canine myocardium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Anti-Monocyte Chemoattractant Protein-1 Gene Therapy Attenuates Left Ventricular Remodeling and Failure After Experimental Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Targeted deletion of CC chemokine receptor 2 attenuates left ventricular remodeling after experimental myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Duality of innate stress responses in cardiac injury, repair, and remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Chemokine expression in myocardial ischemia: MIP-2 dependent MCP-1 expression protects cardiomyocytes from cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

MCP-1/CCL2 protects cardiac myocytes from hypoxia-induced apoptosis by a G(alphai)-independent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

CCL2/Monocyte Chemoattractant Protein-1 regulates inflammatory responses critical to healing myocardial infarcts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Activation of endoplasmic reticulum stress response during the development of ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

C protein-induced myocarditis and subsequent dilated cardiomyopathy: rescue from death and prevention of dilated cardiomyopathy by chemokine receptor DNA therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Coxsackievirus group B type 3 infection upregulates expression of monocyte chemoattractant protein 1 in cardiac myocytes, which leads to enhanced migration of mononuclear cells in viral myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Chemokines and transplant vasculopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Inhibition of chemokine receptor CCR2 and CCR5 expression contributes to simvastatin-induced attenuation of cardiac allograft vasculopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Early and persistent induction of monocyte chemoattractant protein 1 in rat cardiac allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Immunological link between primary graft dysfunction and chronic lung allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Gene transfer of RANTES and MCP-1 chemokine antagonists prolongs cardiac allograft survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Antimonocyte chemoattractant protein-1 gene therapy attenuates graft vasculopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Differential intragraft cytokine messenger RNA profiles during rejection and repair of clinical heart transplants. A longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Failure to down-regulate intragraft cytokine mRNA expression shortly after clinical heart transplantation is associated with high incidence of acute rejection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Critical role for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Chemokine and chemokine receptor gene expression indicates acute rejection of human cardiac transplants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Mechanisms linking obesity with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Inflammation and metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

The macrophage at the crossroads of insulin resistance and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

IKK-beta links inflammation to obesity-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Monocyte chemoattractant protein 1 in obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Monocyte chemoattractant protein-1--a major contributor to the inflammatory process associated with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Increased expression levels of monocyte CCR2 and monocyte chemoattractant protein-1 in patients with diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

CCR2 modulates inflammatory and metabolic effects of high-fat feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Inhibition of CCR2 ameliorates insulin resistance and hepatic steatosis in db/db mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Monocyte chemoattractant protein deficiency fails to restrain macrophage infiltration into adipose tissue [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Murine monocyte chemoattractant protein (MCP)-5: a novel CC chemokine that is a structural and functional homologue of human MCP-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Association between the A-2518G polymorphism in the monocyte chemoattractant protein-1 gene and insulin resistance and Type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

VEGFR-1-selective VEGF homologue PlGF is arteriogenic: evidence for a monocyte-mediated mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Roles of endogenous monocyte chemoattractant protein-1 in ischemia-induced neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Bone Marrow Monocyte Lineage Cells Adhere on Injured Endothelium in a Monocyte Chemoattractant Protein-1–Dependent Manner and Accelerate Reendothelialization as Endothelial Progenitor Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Monocyte chemotactic protein (MCP)-1 promotes angiogenesis via a novel transcription factor, MCP-1-induced protein (MCPIP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

CCL2 regulates angiogenesis via activation of Ets-1 transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Targeted cardiac expression of soluble Fas prevents the development of heart failure in mice with cardiac-specific expression of MCP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Monocyte-specific Bcl-2 expression attenuates inflammation and heart failure in monocyte chemoattractant protein-1 (MCP-1)-induced cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

MCP-1 induces cardioprotection against ischaemia/reperfusion injury: role of reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Cardioprotective effects of cerium oxide nanoparticles in a transgenic murine model of cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

MCP-1/CCL2 as a therapeutic target in myocardial infarction and ischemic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Protection from pulmonary fibrosis in the absence of CCR2 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Costimulation of fibroblast collagen and transforming growth factor beta1 gene expression by monocyte chemoattractant protein-1 via specific receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Monocyte chemoattractant protein-1 enhances gene expression and synthesis of matrix metalloproteinase-1 in human fibroblasts by an autocrine IL-1 alpha loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Apoptosis during wound healing, fibrocontractive diseases and vascular wall injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Monocyte chemoattractant protein-1 induces a novel transcription factor that causes cardiac myocyte apoptosis and ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

A novel CCCH-zinc finger protein family regulates proinflammatory activation of macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

Treatment with bindarit, a blocker of MCP-1 synthesis, protects mice against acute pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080581

21 January 2018

Identifiers

DOI

10.1042/CS20080581

1 reference

20 August 2017

1 reference

PubMed ID

19566488